HIV Vaccines | EK42

Self-assembling nanofiber HIV envelope vaccine elicited stronger neutralization and Fc-mediated functions
Date
June 1, 2021
Speaker
Jui-Lin Chen, BS
Duke University
Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies
Date
June 1, 2021
Speaker
Amelia Escolano, PhD
Rockefeller University
[Joint Session] Welcoming Remarks and Keynote Session
Date
June 1, 2021
Co-Chairs
Persephone Borrow, PhD
University of Oxford
Carine M. Van Lint, PhD
University of Brussels
Accelerating HIV Vaccine Development to Prevent HIV Infection
Date
June 1, 2021
Speaker
M. J. McElrath, MD, PhD
Fred Hutchinson Cancer Research Center
I Am Nothing Without You: The Rationale for T Cell Plus B Cell Vaccines for HIV
Date
June 1, 2021
Speaker
Bruce D. Walker, MD
Ragon Institute of MGH, MIT and Harvard
[Joint Session] Breakthrough Technologies
Date
June 1, 2021
Co-Chairs
Robert F. Siliciano, MD, PhD
Johns Hopkins University School of Medicine
Michael R. Betts, PhD
University of Pennsylvania
Tonsil Organoid Culture System
Date
June 1, 2021
Speaker
Mark M. Davis, PhD
Stanford University School of Medicine
What Have We Learned from HIV-Barcoding Technologies?
Date
June 1, 2021
Speaker
Guillaume J. Filion, PhD
University of Toronto Scarborough
Short Talk: Spatial Profiling of HIV-1 Transmission in Lymphoid Tissues from Humanized Mice and Human Patients with Single-Cell to Single-Virus Resolution
Date
June 1, 2021
Speaker
Collin Kieffer, PhD
University of Illinois at Urbana-Champaign
Short Talk: Visualization of HIV Integration and Latency by CasFISH: In situ Imaging System for Localization of the Provirus and its Transcriptional Regulators in Infected Cells
Date
June 1, 2021
Speaker
Fredrick Kizito, PhD
Case Western Reserve University
Short Talk: Evolutionary Dynamics of HIV-1 Reservoir Cells Revealed by a Novel Multi-Dimensional Single-Cell Assay
Date
June 1, 2021
Speaker
Matthew Osborn, MS
Ragon Institute of MGH, MIT and Harvard
Coffee Break
Date
June 1, 2021
Insights from Preclinical and Clinical Trials
Date
June 1, 2021
Co-Chairs
M. J. McElrath, MD, PhD
Fred Hutchinson Cancer Research Center
Barton F. Haynes, MD
Director, Duke Human Vaccine Institute
AMP Trial Results
Date
June 1, 2021
Speaker
Lawrence Corey, MD
Fred Hutchinson Cancer Research Center
Optimizing Adjuvants for Clinical Vaccine Development
Date
June 1, 2021
Speaker
Sandhya Vasan, MD
US Military HIV Research Program

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.